These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29061405)

  • 21. Continuation phase intravenous ketamine in adults with treatment-resistant depression.
    Vande Voort JL; Morgan RJ; Kung S; Rasmussen KG; Rico J; Palmer BA; Schak KM; Tye SJ; Ritter MJ; Frye MA; Bobo WV
    J Affect Disord; 2016 Dec; 206():300-304. PubMed ID: 27656788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketamine and Treatment-Resistant Depression.
    Lent JK; Arredondo A; Pugh MA; Austin PN
    AANA J; 2019 Oct; 87(5):411-419. PubMed ID: 31612847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder.
    Sterpenich V; Vidal S; Hofmeister J; Michalopoulos G; Bancila V; Warrot D; Dayer A; Desseilles M; Aubry JM; Kosel M; Schwartz S; Vutskits L
    Anesthesiology; 2019 Jun; 130(6):923-935. PubMed ID: 31021848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remission of treatment-resistant depression with electroconvulsive therapy and ketamine.
    Niemegeers P; Schrijvers D; Madani Y; Sabbe BG
    J ECT; 2014 Sep; 30(3):e31-2. PubMed ID: 24625710
    [No Abstract]   [Full Text] [Related]  

  • 25. A new indication for esketamine nasal spray (Spravato).
    Med Lett Drugs Ther; 2020 Sep; 62(1607):151. PubMed ID: 32960869
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of Low-Dose Ketamine Infusion on the Positive and Negative Domains of Hopelessness and Suicidal Thoughts.
    Lin WC; Chen MH; Su TP; Li CT; Wu HJ; Tsai SJ; Bai YM; Mao WC; Tu PC
    J Clin Psychiatry; 2024 Jul; 85(3):. PubMed ID: 39028544
    [No Abstract]   [Full Text] [Related]  

  • 27. Ketamine for chronic depression: two cautionary tales.
    Talbot J; Phillips JL; Blier P
    J Psychiatry Neurosci; 2019 Nov; 44(6):384-385. PubMed ID: 31573153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline cognitive function predicts full remission of suicidal symptoms among patients with treatment-resistant depression and strong suicidal ideation after low-dose ketamine infusion.
    Lin WC; Su TP; Li CT; Wu HJ; Tsai SJ; Bai YM; Tu PC; Chen MH
    J Psychopharmacol; 2023 Aug; 37(8):795-801. PubMed ID: 37332247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous ketamine for treatment-resistant major depressive disorder.
    Covvey JR; Crawford AN; Lowe DK
    Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine Sedation of the Pregnant Patient With Acute Suicidal Ideation During Air Medical Transfer.
    Cong ML; Markwell S; Robertson L
    Air Med J; 2020; 39(2):143-144. PubMed ID: 32197694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketamine versus electroconvulsive therapy for treatment-resistant depression: An updated meta-analysis of randomized clinical trials.
    Shafiee A; Soltani Abhari F; Jafarabady K; Bakhtiyari M
    Asian J Psychiatr; 2023 Oct; 88():103720. PubMed ID: 37572523
    [No Abstract]   [Full Text] [Related]  

  • 32. Time-Course of Depression Improvement With Ketamine Adjunction in Electroconvulsive Therapy.
    Romeo B; Choucha W; Fossati P; Rotge JY
    J ECT; 2016 Jun; 32(2):80-1. PubMed ID: 26766630
    [No Abstract]   [Full Text] [Related]  

  • 33. The promise of ketamine for treatment-resistant depression: current evidence and future directions.
    DeWilde KE; Levitch CF; Murrough JW; Mathew SJ; Iosifescu DV
    Ann N Y Acad Sci; 2015 May; 1345(1):47-58. PubMed ID: 25649308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. All Suicidal Ideation Is Not Created Equal: Two Cases of Suicide Attempts During Maintenance Ketamine Treatment.
    Cusin C; Sakurai H; Bentley K; Pedrelli P; Foster S; Fava M; Mischoulon D
    Am J Psychiatry; 2020 Feb; 177(2):173-174. PubMed ID: 32008389
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study.
    Vidal S; Gex-Fabry M; Bancila V; Michalopoulos G; Warrot D; Jermann F; Dayer A; Sterpenich V; Schwartz S; Vutskits L; Khan N; Aubry JM; Kosel M
    J Clin Psychopharmacol; 2018 Dec; 38(6):590-597. PubMed ID: 30346333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketamine for the treatment of depression: what about the addictive potential?
    Hillemacher T; Bleich S; Demling J; Kornhuber J
    Aust N Z J Psychiatry; 2007 Sep; 41(9):772-3. PubMed ID: 17896416
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of ketamine in electroconvulsive therapy.
    Kucia K; Merk W
    Psychiatr Pol; 2015; 49(6):1255-63. PubMed ID: 26909400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketamine for treatment-resistant depression: ready or not for clinical use?
    Rush AJ
    Am J Psychiatry; 2013 Oct; 170(10):1079-81. PubMed ID: 23982324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.